| PubMed |
Abstract |
RScore(About this table) |
| 12542507 |
Fernandez O, Arbizu T, Izquierdo G, Martinez-Yelamos A, Gata JM, Luque G, de Ramon E: Clinical benefits of interferon beta-1a in relapsing-remitting MS: a phase IV study. Acta Neurol Scand. 2003 Jan;107(1):7-11.
OBJECTIVE: To evaluate the efficacy and safety of IFNbeta-1a (Avonex, Biogen, Inc., Cambridge, MA, USA) in patients with relapsing-remitting multiple sclerosis (MS). |
5(0,0,0,5) |
Details |
| 12195454 |
Fernandez O, Guerrero M, Mayorga C, Munoz L, Lean A, Luque G, Hervas M, Fernandez V, Capdevila A, de Ramon E: Combination therapy with interferon beta-1b and azathioprine in secondary progressive multiple sclerosis. J Neurol. 2002 Aug;249(8):1058-62.
Patients with SPMS were eligible for this non-controlled prospective study if they had two or more relapses requiring corticosteroid treatment or deteriorated by at least 0.5 points on the Expanded Disability Status Scale (EDSS) while on IFNB-1b in the year preceeding the study. |
3(0,0,0,3) |
Details |
| 11437159 |
Fernandez O, Mayorga C, Luque G, Guerrero M, Guerrero R, Leyva L, Leon A, Blanca M: Study of binding and neutralising antibodies to interferon-beta in two groups of relapsing-remitting multiple sclerosis patients. J Neurol. 2001 May;248(5):383-8.
|
1(0,0,0,1) |
Details |